PLP2 and neoplasm: For example, CI.1040, Nutlin.3a, PF.02341066, Metformin, EHT.1864, and LFM.A13 had higher drug sensitivities in high PLP2+ Tumor EPCs group than in low PLP2+ Tumor EPCs score group.